CommSec's Tom Piotrowski speaks with Oventus Medical (OVN) Clinical Director & Co-Founder, Dr Chris Hart about:
- OVN’s Airway Technology and how it compares to Continuous Positive Airway Pressure (CPAP) devices which are commonly used to treat individual suffering from obstructive sleep apnoea and problem snoring.
- OVN’s plans for the commercial rollout of its O2Vent product following FDA clearance, which will see exclusive distribution in the US by OVN’s distribution partner Modern Dental – which covers approximately one quarter of US dentists through 34,000 dental offices.
To view more Executive Series interviews, visit:
Please sign in to comment on this wire.